Home
About Nanexa
Pharmashell®
Projects
Investors
Media
Contact
English
- Swedish

Annual General Meeting 2023

10 May, 2023 - Bolagsstämma

The 2023 Annual General Meeting will be held on 9 June 2023.

Bilagor

Notice of AGM June 9, 2023 Nanexa AB

Proxy form, Nanexa AB

The board's proposal on amendment of the articles of association

The board of directors' proposal for resolution on warrant-based incentive program for all employees

Terms and conditions for warrants of series 2023_2026

Annual Report 2023

Nanexa is a pharmaceutical company developing injectable drug products based on the proprietary and innovative drug delivery system PharmaShell® – the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. Nanexa develops its own products and also has collaboration agreements with several pharma companies, among others AstraZeneca.

CONTACT

Nanexa AB, Virdings Allé 2, SE-75450 Uppsala, Sweden
Phone: +46 (0) 18 100 300
E-mail: info@nanexa.se
Org nr. 556833-0285

Integritetspolicy
Integritetspolicy för aktieägare

English
Svenska